Dr. Mark A. Sellmyer’s interdisciplinary approach combines molecular imaging with chemical biology to create innovative diagnostic and therapeutic tools. His work includes developing radiotracers for cancer imaging and investigating immune cell dynamics in tumors. Dr. Sellmyer’s research aims to provide critical insights into the mechanisms of immunotherapy and enhance clinical cancer care.
Projects and Grants
Combining Molecular Imaging and Translational Chemical Biology to Improve Cancer Immunotherapies
University of Pennsylvania | All cancers | 2024